MyFinsight
Home
Blog
About
Back
Cash Flow
Estrella Immunopharma, Inc. (ESLA)
Estrella Immunopharma, Inc. (ESLA)
source: myfinsight.com
Proceeds received from
exercise of prefunded...
$4
Net cash provided by
financing activities
$4
(-100.00%↓ Y/Y)
Net change in cash
and cash...
-$1,780,734
(-545.54%↓ Y/Y)
Canceled cashflow
$4
something is missing
$4,125,000
Change in fair value of
derivative liabilities
$222,092
Stock-based compensation
$145,298
(-54.34%↓ Y/Y)
Other payables and
accrued liabilities
$76,477
(184.05%↑ Y/Y)
Prepaid expenses and
other receivables
-$51,783
(90.75%↑ Y/Y)
Net cash used in
operating activities
-$1,780,738
(-102.16%↓ Y/Y)
Canceled cashflow
$4,620,650
Accrued liability -
related party
-$4,088,334
(-168.35%↓ Y/Y)
Net loss
-$2,306,339
(69.85%↑ Y/Y)
Accounts payable -
related party
-$6,715
(-280.56%↓ Y/Y)
Back